KemPharm to Report Second Quarter 2021 Results
Retrieved on:
Thursday, August 5, 2021
Company, Benzhydrocodone, Webcast, Attention deficit hyperactivity disorder, Investor relations, Technology, KMPH, IH, YouTube, Sedona Airport, Twitter, CNS, Hydrocodone, Paracetamol, Ligand, Sud, Food and Drug Administration, Conference call, ID, Idiopathic hypersomnia, Second, Conference, LinkedIn, Nasdaq, Facebook, GLOBE, Communications satellite, Pharmaceutical industry
CELEBRATION, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that the Company will host a conference call and live audio webcast on Thursday, August 12, 2021, at 4:30 p.m. ET, to discuss its corporate and financial results for the second quarter 2021.
Key Points:
- ET, to discuss its corporate and financial results for the second quarter 2021.
- Investors may submit questions to KemPharm prior to the Second Quarter 2021 Results conference call by e-mail to [email protected] .
- Please use the e-mail subject heading KemPharm Second Quarter 2021 Question to ensure that the information is received.
- For more information on KemPharm and its pipeline of prodrug product candidates visit www.kempharm.com or connect with us on Twitter , LinkedIn , Facebook and YouTube .